Abstract
The endocrine state of hypogonadism is well-known to urologists and something that is commonly addressed in outpatient encounters around the world. Testosterone supplementation has exploded over the past decade, likely a combined consequence of direct-to-consumer advertising as well as a deeper understanding of the complex underlying physiology and potential health benefits associated with a eugonadal state. In this study, the authors further push the boundary of our understanding of this complex interplay between sex hormones and tissue health in a way that could stand to benefit genitourinary reconstruction outcomes.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
